Insulin as an Amyloid-Fibril Protein at Sites of Repeated Insulin Injections in a Diabetic Patient

Diabetologia - Germany
doi 10.1007/bf00276849
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Diabetic Ketoacidosis: Should Current Management Include Subcutaneous Insulin Injections?

The Southwest Respiratory and Critical Care Chronicles
2017English

Repeated Hypoglycemia Caused by the Overproduction of Anti-Insulin Antibodies and Isolated ACTH Deficiency in a Type 2 Diabetic Patient Receiving Insulin Therapy

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2013English

Technique of Insulin Injections

BMJ
1940English

Insulin Injections and Infections.

BMJ
1981English

A Novel Approach to Preventing Diabetic Ketoacidosis in a Patient Treated With an Insulin Pump

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2003English

Appendix Insulin Secreting Neuroendocrine Tumor in a Diabetic Patient: A Challenging Diagnosis.

Journal of Gastroenterology, Pancreatology & Liver Disorders
2017English

Amyloid-Like Fibril Formation in an All Β-Barrel Protein

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2003English

Successful Treatment of Insulin Allergy in a Type 1 Diabetic Patient by Means of Constant Subcutaneous Pump Infusion of Insulin

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2003English

Acanthosis Nigricans at Sites of Insulin Injection in a Man With Diabetes

CMAJ
Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy